BioSpace News Archive

BioCapital

Briefing: Point-of-Care Testing--Bringing the Lab to the Patient

Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing

October 2, 2019
·
2 min read
Policy

MGI Sues Illumina Again for Patent Infringement in the United States

Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California.

October 2, 2019
·
2 min read
Policy

FDA Accepts Two Applications for Merck’s DIFICID® (fidaxomicin) to Treat Children Aged Six Months Up to 18 years with Clostridium difficile Infections

DIFICID® Pediatric Filings Receive Priority Review Classification

October 2, 2019
·
8 min read
Genetown

Sage Therapeutics to Participate in J.P. Morgan Executive Conference Call Series

Enrollment complete in the Phase 3 MOUNTAIN Study evaluating SAGE-217 in the treatment of major depressive disorder (MDD); topline results expected in 4Q 2019

October 2, 2019
·
2 min read
Business

Hollister Incorporated Announces Grand Opening of New Manufacturing Facility in Kaunas, Lithuania

Hollister Incorporated, an independent, employee-owned company that develops, manufactures, and markets healthcare products worldwide, announced the official grand opening of its new manufacturing facility in Kaunas, Lithuania, located in the Kaunas FEZ region.

October 2, 2019
·
3 min read
Business

The United States Pharmacopeia selected by USAID to strengthen systems that improve the quality of medical products in low- and middle-income countries

New program builds on USP’s and USAID’s longstanding cooperation to advance access to quality-assured medical products and address the proliferation of poor-quality medical products

October 2, 2019
·
3 min read
Policy

Merck’s KEYTRUDA® (pembrolizumab) Now Approved as Monotherapy in China for First-Line Treatment of Certain Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1

KEYTRUDA is First Anti-PD-1 Therapy Approved as Monotherapy and in Combination with Chemotherapy in First-Line Setting for NSCLC in China

October 2, 2019
·
31 min read
Deals

CORA Physical Therapy Expands Virginia Presence with Acquisition of Three Clinics in Blacksburg Area

CORA Health Services, Inc. announced that it has broadened its coverage in Virginia with the acquisition of Blacksburg Physical Therapy Associates, Inc..

October 2, 2019
·
2 min read
Policy

Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test

Enabling on-demand monitoring of BCR-ABL levels in patients with Chronic Myeloid Leukemia

October 2, 2019
·
2 min read
Drug Development

Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program

This is the second program to enter pre-clinical studies; In addition, Prof. David T. Rubin, joins Biomica as a Scientific & Medical Advisor

October 2, 2019
·
7 min read